Quick Answer
ROCKWELL MEDICAL, INC. reported Long Term Debt of $8.83 million for the year ending 2025.
- ROCKWELL MEDICAL, INC. showed an increase of +4.2% in Long Term Debt from 2024 to 2025.
- This data is from ROCKWELL MEDICAL, INC.'s annual report (Form 10-K), filed with the SEC on March 26, 2026.
- XBRL data for this metric is available from 2013 to 2025 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2013: $20.00 million | Q3 2013: $19.43 million | Q1 2014: $16.22 million | Q2 2014: $14.48 million | Q3 2014: $12.05 million | Q1 2020: $20.68 million | Q2 2020: $20.76 million | Q3 2020: $20.86 million | Q1 2021: $21.04 million | Q2 2021: $0.00 | Q3 2021: $14.09 million | Q1 2022: $11.78 million | Q2 2022: $10.37 million | Q3 2022: $8.96 million | Q1 2023: $6.15 million | Q2 2023: $4.74 million | Q3 2023: $3.33 million | Q1 2024: $8.27 million | Q2 2024: $8.30 million | Q3 2024: $8.38 million | Q1 2025: $8.56 million | Q2 2025: $8.65 million | Q3 2025: $8.74 million.
- Over the full 8 years of available data (2013 to 2025), ROCKWELL MEDICAL, INC.'s Long Term Debt has declined by 50.7%.
- Historical annual values: Fiscal year 2025: $8.83 million | Fiscal year 2024: $8.47 million | Fiscal year 2023: $8.29 million | Fiscal year 2022: $7.56 million | Fiscal year 2021: $13.19 million | Fiscal year 2020: $20.95 million | Fiscal year 2019: $0.00 | Fiscal year 2013: $17.92 million.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: